T. Rowe Price Associates’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240M Buy
405,447
+53,361
+15% +$26.6M 0.03% 416
2025
Q4
$172M Buy
352,086
+51,155
+17% +$23.8M 0.02% 504
2025
Q3
$126M Buy
300,931
+186,429
+163% +$62.7M 0.01% 568
2025
Q2
$32.9M Sell
114,502
-75,229
-40% -$22.5M ﹤0.01% 842
2025
Q1
$58.5M Sell
189,731
-208,151
-52% -$71.3M 0.01% 678
2024
Q4
$140M Buy
397,882
+53,355
+15% +$19.6M 0.02% 499
2024
Q3
$123M Buy
344,527
+109,611
+47% +$37M 0.01% 527
2024
Q2
$74.8M Buy
234,916
+207,940
+771% +$55M 0.01% 607
2024
Q1
$6.2M Sell
26,976
-5,069
-16% -$1.14M ﹤0.01% 1180
2023
Q4
$7.05M Buy
32,045
+7,704
+32% +$1.78M ﹤0.01% 1156
2023
Q3
$5.5M Sell
24,341
-194
-0.8% -$44.7K ﹤0.01% 1160
2023
Q2
$5.42M Buy
24,535
+431
+2% +$95.5K ﹤0.01% 1177
2023
Q1
$5.4M Buy
24,104
+596
+3% +$147K ﹤0.01% 1167
2022
Q4
$6.54M Buy
23,508
+672
+3% +$170K ﹤0.01% 1131
2022
Q3
$4.78M Sell
22,836
-109,938
-83% -$24.6M ﹤0.01% 1214
2022
Q2
$31.3M Buy
132,774
+73,913
+126% +$15M ﹤0.01% 1034
2022
Q1
$10.6M Buy
58,861
+143
+0.2% +$27.2K ﹤0.01% 1358
2021
Q4
$12.7M Sell
58,718
-1,516
-3% -$298K ﹤0.01% 1373
2021
Q3
$11.1M Sell
60,234
-1,021
-2% -$201K ﹤0.01% 1407
2021
Q2
$11M Sell
61,255
-292,869
-83% -$55.8M ﹤0.01% 1403
2021
Q1
$59.2M Buy
354,124
+110,623
+45% +$18.4M 0.01% 944
2020
Q4
$37M Buy
243,501
+210,999
+649% +$27.7M ﹤0.01% 1054
2020
Q3
$3.28M Sell
32,502
-975
-3% -$107K ﹤0.01% 1458
2020
Q2
$4.05M Sell
33,477
-221,354
-87% -$24.9M ﹤0.01% 1408
2020
Q1
$24.2M Buy
254,831
+208,234
+447% +$19.8M ﹤0.01% 1006
2019
Q4
$4.1M Buy
46,597
+5,096
+12% +$448K ﹤0.01% 1434
2019
Q3
$3.31M Buy
41,501
+248
+0.6% +$20K ﹤0.01% 1448
2019
Q2
$3.22M Buy
41,253
+19
+0% +$1.78K ﹤0.01% 1465
2019
Q1
$4.84M Buy
41,234
+393
+1% +$45.8K ﹤0.01% 1406
2018
Q4
$4.45M Buy
40,841
+125
+0.3% +$14.5K ﹤0.01% 1414
2018
Q3
$5.21M Sell
40,716
-2,704
-6% -$334K ﹤0.01% 1449
2018
Q2
$4.91M Sell
43,420
-88,361
-67% -$9.71M ﹤0.01% 1437
2018
Q1
$14.8M Sell
131,781
-1,069
-0.8% -$136K ﹤0.01% 1268
2017
Q4
$19.7M Sell
132,850
-48,305
-27% -$6.14M ﹤0.01% 1197
2017
Q3
$21.2M Buy
181,155
+3,710
+2% +$474K ﹤0.01% 1158
2017
Q2
$23M Buy
177,445
+6,100
+4% +$761K ﹤0.01% 1119
2017
Q1
$23.2M Sell
171,345
-3,837
-2% -$581K ﹤0.01% 1095
2016
Q4
$25.1M Sell
175,182
-6,878
-4% -$878K 0.01% 1063
2016
Q3
$21.5M Buy
182,060
+15,254
+9% +$1.83M ﹤0.01% 1101
2016
Q2
$17.7M Sell
166,806
-4,607
-3% -$514K ﹤0.01% 1139
2016
Q1
$19.1M Buy
171,413
+580
+0.3% +$73.4K ﹤0.01% 1091
2015
Q4
$26.8M Sell
170,833
-582,731
-77% -$84.8M 0.01% 993
2015
Q3
$98.9M Sell
753,564
-148,448
-16% -$23.8M 0.02% 577
2015
Q2
$157M Sell
902,012
-32,254
-3% -$5.8M 0.03% 494
2015
Q1
$161M Sell
934,266
-22,629
-2% -$3.45M 0.03% 487
2014
Q4
$124M Buy
956,895
+100,389
+12% +$12.9M 0.03% 555
2014
Q3
$110M Buy
856,506
+42,654
+5% +$4.4M 0.02% 579
2014
Q2
$72M Buy
813,852
+8,295
+1% +$798K 0.02% 736
2014
Q1
$75.7M Buy
805,557
+317,037
+65% +$32.4M 0.02% 717
2013
Q4
$55.2M Buy
488,520
+179,600
+58% +$16.2M 0.01% 804
2013
Q3
$24.4M Buy
308,920
+4,300
+1% +$314K 0.01% 1028
2013
Q2
$20.1M Buy
+304,620
New +$19.6M 0.01% 1067

Other funds holding UTHR